Disclosed are novel proteins, referred to as tumor necrosis factor binding proteins, that modulate the activity of tumor necrosis factor. Also disclosed are processes for obtaining the tumor necrosis binding proteins by recombinant genetic engineering techniques.

 
Web www.patentalert.com

< Process for correction of a disulfide misfold in Fc molecules

< Heterocyclic GPR40 modulators

> Thermally insulated apparatus for liquid chromatographic analysis

> Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
~ 00615